Neuromodulation trials

Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHAS

RecruitingNCT06991062Phase: NAStarted 2025-02-19

Summary

The goal of this clinical research study is to learn more about whether individual differences in brain responses to emotional triggers impact rTMS (repetitive transcranial magnetic stimulation) respo

Eligibility

Sex
ALL
Min Age
21 Years
Max Age
60 Years

Locations

The University of Texas M. D. Anderson Cancer CenterHouston, Texas, United States

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06991062